001     167339
005     20240229133537.0
024 7 _ |a pmid:33534179
|2 pmid
024 7 _ |a 0020-7136
|2 ISSN
024 7 _ |a 1097-0215
|2 ISSN
024 7 _ |a doi: 10.1002/ijc.33475.
|2 doi
037 _ _ |a DKFZ-2021-00286
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Corradi, Chiara
|b 0
245 _ _ |a Genome-wide scan of long noncoding RNA single nucleotide polymorphisms and pancreatic cancer susceptibility.
260 _ _ |a Bognor Regis
|c 2021
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1619611891_10127
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2021 Jun 1;148(11):2779-2788
520 _ _ |a Pancreatic ductal adenocarcinoma (PDAC) is projected to become the second cancer-related cause of death by 2030. Identifying novel risk factors, including genetic risk loci, could be instrumental in risk stratification and implementation of prevention strategies. Long noncoding RNAs (lncRNAs) are involved in regulation of key biological processes, and the possible role of their genetic variability has been unexplored so far. Combining genome wide association studies and functional data, we investigated the genetic variability in all lncRNAs. We analyzed 9893 PDAC cases and 9969 controls and identified a genome-wide significant association between the rs7046076 SNP and risk of developing PDAC (P = 9.73 × 10-9 ). This SNP is located in the NONHSAG053086.2 (lnc-SMC2-1) gene and the risk allele is predicted to disrupt the binding of the lncRNA with the micro-RNA (miRNA) hsa-mir-1256 that regulates several genes involved in cell cycle, such as CDKN2B. The CDKN2B region is pleiotropic and its genetic variants have been associated with several human diseases, possibly though an imperfect interaction between lncRNA and miRNA. We present a novel PDAC risk locus, supported by a genome-wide statistical significance and a plausible biological mechanism.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|x 0
|f POF IV
588 _ _ |a Dataset connected to PubMed,
650 _ 7 |a association study
|2 Other
650 _ 7 |a long noncoding RNA
|2 Other
650 _ 7 |a pancreatic cancer
|2 Other
650 _ 7 |a single nucleotide polymorphism
|2 Other
700 1 _ |a Gentiluomo, Manuel
|b 1
700 1 _ |a Gajdán, László
|b 2
700 1 _ |a Cavestro, Giulia Martina
|b 3
700 1 _ |a Kreivenaite, Edita
|b 4
700 1 _ |a Di Franco, Gregorio
|b 5
700 1 _ |a Sperti, Cosimo
|b 6
700 1 _ |a Giaccherini, Matteo
|b 7
700 1 _ |a Petrone, Maria Chiara
|b 8
700 1 _ |a Tavano, Francesca
|0 0000-0002-8831-7349
|b 9
700 1 _ |a Gioffreda, Domenica
|b 10
700 1 _ |a Morelli, Luca
|b 11
700 1 _ |a Soucek, Pavel
|0 0000-0002-4294-6799
|b 12
700 1 _ |a Andriulli, Angelo
|b 13
700 1 _ |a Izbicki, Jakob R
|b 14
700 1 _ |a Napoli, Niccolò
|b 15
700 1 _ |a Małecka-Panas, Ewa
|b 16
700 1 _ |a Hegyi, Péter
|b 17
700 1 _ |a Neoptolemos, John P
|b 18
700 1 _ |a Landi, Stefano
|b 19
700 1 _ |a Vashist, Yogesh
|b 20
700 1 _ |a Pasquali, Claudio
|b 21
700 1 _ |a Lu, Ye
|0 P:(DE-He78)ebb819874e9553d89bd480e6811dc0f3
|b 22
|u dkfz
700 1 _ |a Cervena, Klara
|b 23
700 1 _ |a Theodoropoulos, George E
|b 24
700 1 _ |a Moz, Stefania
|b 25
700 1 _ |a Capurso, Gabriele
|b 26
700 1 _ |a Strobel, Oliver
|b 27
700 1 _ |a Carrara, Silvia
|b 28
700 1 _ |a Hackert, Thilo
|b 29
700 1 _ |a Hlavac, Viktor
|b 30
700 1 _ |a Archibugi, Livia
|b 31
700 1 _ |a Oliverius, Martin
|b 32
700 1 _ |a Vanella, Giuseppe
|b 33
700 1 _ |a Vodicka, Pavel
|b 34
700 1 _ |a Arcidiacono, Paolo Giorgio
|b 35
700 1 _ |a Pezzilli, Raffaele
|b 36
700 1 _ |a Milanetto, Anna Caterina
|b 37
700 1 _ |a Lawlor, Rita T
|b 38
700 1 _ |a Ivanauskas, Audrius
|b 39
700 1 _ |a Szentesi, Andrea
|b 40
700 1 _ |a Kupcinskas, Juozas
|b 41
700 1 _ |a Testoni, Sabrina G G
|b 42
700 1 _ |a Lovecek, Martin
|b 43
700 1 _ |a Nentwich, Michael
|b 44
700 1 _ |a Gazouli, Maria
|0 0000-0002-3295-6811
|b 45
700 1 _ |a Luchini, Claudio
|b 46
700 1 _ |a Zuppardo, Raffaella Alessia
|b 47
700 1 _ |a Darvasi, Erika
|b 48
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 49
|u dkfz
700 1 _ |a Gheorghe, Cristian
|b 50
700 1 _ |a Jamroziak, Krzysztof
|b 51
700 1 _ |a Canzian, Federico
|0 P:(DE-He78)5323704270b6393dcea70186ffd86bca
|b 52
|u dkfz
700 1 _ |a Campa, Daniele
|0 0000-0003-3220-9944
|b 53
773 _ _ |a 10.1002/ijc.33475.
|0 PERI:(DE-600)1474822-8
|n 11
|p 2779-2788
|t International journal of cancer
|v 148
|y 2021
|x 0020-7136
909 C O |o oai:inrepo02.dkfz.de:167339
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 22
|6 P:(DE-He78)ebb819874e9553d89bd480e6811dc0f3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 49
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 52
|6 P:(DE-He78)5323704270b6393dcea70186ffd86bca
913 0 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2020-08-32
|w ger
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2020-08-32
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b INT J CANCER : 2018
|d 2020-08-32
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-08-32
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-08-32
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-08-32
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2020-08-32
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-08-32
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2020-08-32
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2020-08-32
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2020-08-32
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-08-32
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2020-08-32
920 1 _ |0 I:(DE-He78)C055-20160331
|k C055
|l C055 Genomische Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 1
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 2
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C055-20160331
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21